首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

市場調查報告書

商品編碼

2075308

低分子量預填充式注射器市場：按類型、材料、應用、分銷管道和地區分類

Small Molecule Prefilled Syringes Market, By Type, By Material Type, By Application, By Distribution Channel, By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，小分子預填充式注射器市場規模將達到 221.4 億美元，到 2033 年將達到 320 億美元。預計 2026 年至 2033 年的複合年成長率為 5.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	221.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.40%	2033年市場規模預測：	320億美元

預填充式注射器相比傳統的管瓶包裝具有諸多優勢，其中之一便是使用便捷。使用預填充式注射器無需像管瓶包裝藥物那樣進行預先給藥程序。此外，預填充式注射器已預先填充了正確的劑量，有助於防止給藥錯誤。許多製藥企業為了確保最終用戶獲得正確的劑量，會在管瓶填充高達25%的過量液體。然而，這種過量填充會導致錯誤，而預充式注射器幾乎可以完全避免此類錯誤。這尤其具有顯著優勢，尤其是在引入昂貴的生物製藥產品時，特別是當某些疫苗供不應求或價格極其昂貴時，預填充式注射器可以減少廢棄物。

市場動態

市場相關人員正著力關注新產品的上市和核准，預計有助於推動全球小分子預填充式注射器市場在預測期內的成長。例如，2018年3月，羅氏集團旗下子公司基因泰克宣布，美國食品藥物管理局（FDA）已批准Lucentis（雷珠單抗注射液）0.3毫克預填充式注射器（PFS）作為治療各種類型糖尿病視網膜病變的新給藥方式。

市場新進業者正致力於推出預填充式注射器的生產能力，預計將推動預測期內的市場成長。例如，總部位於日本的Terumo Corporation於2019年7月宣布，將在其子公司Terumo Corporation茂山口D&D新建一座預填充式注射器生產設施。

市場相關人員對產品上市的關注預計將推動全球小分子預填充式注射器市場的成長。例如，2020年3月，大型跨國製藥公司瑞迪博士實驗室有限公司宣佈在印度推出“鹽酸納洛酮注射液USP，2毫克/2毫升（1毫克/毫升）單劑量預填充式注射器”，這是“鹽酸納洛酮注射液USP”的治療等學名藥版本。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球小分子預填充式注射器市場的主要參與者進行了分析：公司概況、財務業績、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
本報告提供的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球小分子量預填充式注射器市場」報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球小分子預填充式注射器市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- BD
- Cytiva
- Merck KGaA
- Gaplast
- Ascendia Pharmaceuticals
- Sanofi
- Viatris Inc.（Mylan NV）
- Pfizer Inc.
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- McKesson Corporation
- Analysts'Views

第10章

參考
調查方法

簡介目錄

Product Code: CMI1629

Small Molecule Prefilled Syringes Market is estimated to be valued at USD 22.14 Bn in 2026 and is expected to reach USD 32.00 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 22.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.40%	2033 Value Projection:	USD 32.00 Bn

Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.

Market Dynamics

Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.

Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.

Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global small molecule prefilled syringes market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market

Detailed Segmentation:

Global Small Molecule Prefilled Syringes Market, By Drug Class (Revenue, USD Bn, 2021 - 2033)
Cardiovascular Drugs
Neurology Drugs
Analgesics
Adjuvants
Others
Global Small Molecule Prefilled Syringes Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
Glass
Plastic & Polymer
Global Small Molecule Prefilled Syringes Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Small Molecule Prefilled Syringes Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country:
  - U.S.
  - Canada
Latin America
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Drug Class:
  - Cardiovascular Drugs
  - Neurology Drugs
  - Analgesics
  - Adjuvants
  - Others
- By Material Type:
  - Glass
  - Plastic & Polymer
- By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Sanofi *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Viatris Inc. (Mylan N.V.)
AstraZeneca Plc
F. Hoffmann-La Roche AG (Genentech, Inc.)
Sun Pharmaceutical Industries Ltd.
Pfizer Inc.
Dr. Reddy's Laboratories Ltd.
Teva Pharmaceutical Industries Ltd.
Fresenius Kabi AG
McKesson Corporation.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Material Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Market Trends
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER'S Analysis
Industry Trends
Product Launches and Approvals

4. Global Small Molecule Prefilled Syringes Market, By Type, 2021- 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Single-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Dual-chamber Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Customized Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

5. Global Small Molecule Prefilled Syringes Market, By Material Type, 2021- 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Plastic & Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

6. Global Small Molecule Prefilled Syringes Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Opthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Anaphylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Others (Thrombosis, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

7. Global Small Molecule Prefilled Syringes Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

8. Global Small Molecule Prefilled Syringes Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, andY-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- BD
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cytiva
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gaplast
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ascendia Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sanofi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Viatris Inc. (Mylan N.V.)
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- McKesson Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Analysts' Views